Nov 5, 2025 9:15am EST Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025
Aug 7, 2025 8:30am EDT Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies